ARCHIVES

Reauthorization Bill Ready For Senate Floor; Report to Panel Makes Clear Why Renewal Needed

This article is from The Cancer Letter archive.

Vol. 14 No. 17 | April 22, 1988

Download PDF Visit The Full Archive

Related Articles

Youth Smoking Begins To Decline, NCI Says

April 5, 2002

In Brief: Cancer Panel To Meet In Seattle, Houston, Chicago; Wisconsin’s Robert Johnson Dies; Goldin Retires

August 27, 1982

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004

Cancer survivors number 9.8 million in U.S., CDC says.

June 25, 2004

Aranesp Improved Anemia In MDS In Phase II Trial

September 30, 2005

RFAs For New Improve Accrual Of Minorities, Women

February 2, 1996